Adding 5-hydroxytryptamine receptor type 3 antagonists may reduce drug-induced nausea in poor insight obsessive-compulsive patients taking off-label doses of selective serotonin re...

by Martino Matteo, Fornaro Michele
Published 2010-12-01

An open pilot study of zonisamide augmentation in major depressive patients not responding to a low dose trial with duloxetine: preliminary results on tolerability and clinical eff...

by Benvenuti Marzia, Colicchio Salvatore, Dalmasso Bruna, Martino Matteo, Fornaro Michele, Rocchi Giulio, Escelsior Andrea, Perugi Giulio
Published 2011-09-01